InvestorsHub Logo
Followers 2
Posts 356
Boards Moderated 0
Alias Born 06/16/2017

Re: Ihub1232 post# 19293

Saturday, 09/15/2018 3:53:26 PM

Saturday, September 15, 2018 3:53:26 PM

Post# of 41246
I’d speculate that they may have received more but only for the benefit of the other company to avoid this product from eventually stealing market share. As a company I’d take 10 mill with royalties for the next ten years vs. 20 mill and nothing to show for it. For CTL, they can leverage their strengths and capitalize on selling something superior to like products. Win-win. I would have liked to see more, but been saying for years they should focus on R&D and license. Only 22 employees no way to ramp sales it was clear. They needed to get the product in more hands. The same holds true fore the biomaterial which is their holy grail.. This new avenue will open them up for growth and large deals. Long term I have no doubt, still curious what we see short term as they ramp up.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SINT News